These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 36615205)

  • 21. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
    Moosavian SA; Bianconi V; Pirro M; Sahebkar A
    Semin Cancer Biol; 2021 Feb; 69():337-348. PubMed ID: 31585213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures.
    Ragelle H; Danhier F; Préat V; Langer R; Anderson DG
    Expert Opin Drug Deliv; 2017 Jul; 14(7):851-864. PubMed ID: 27730820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp method.
    Merlo-Mas J; Tomsen-Melero J; Corchero JL; González-Mira E; Font A; Pedersen JN; García-Aranda N; Cristóbal-Lecina E; Alcaina-Hernando M; Mendoza R; Garcia-Fruitós E; Lizarraga T; Resch S; Schimpel C; Falk A; Pulido D; Royo M; Schwartz S; Abasolo I; Pedersen JS; Danino D; Soldevila A; Veciana J; Sala S; Ventosa N; Córdoba A
    J Supercrit Fluids; 2021 Jul; 173():105204. PubMed ID: 34219919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of Continuous Manufacturing for Liposomal Drug Products.
    Worsham RD; Thomas V; Farid SS
    Biotechnol J; 2019 Feb; 14(2):e1700740. PubMed ID: 29781114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liposomal formulations of amphotericin B: differences according to the scientific evidence.
    Azanza JR; Sádada B; Reis J
    Rev Esp Quimioter; 2015 Dec; 28(6):275-81. PubMed ID: 26621170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation.
    Pallagi E; Ambrus R; Szabó-Révész P; Csóka I
    Int J Pharm; 2015 Aug; 491(1-2):384-92. PubMed ID: 26134895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Product Development, Manufacturing, and Packaging of Solid Dosage Forms Under QbD and PAT Paradigm: DOE Case Studies for Industrial Applications.
    Singh BN
    AAPS PharmSciTech; 2019 Sep; 20(8):313. PubMed ID: 31529232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®.
    Jaffar-Aghaei M; Khanipour F; Maghsoudi A; Sarvestani R; Mohammadian M; Maleki M; Havasi F; Rahmani H; Karagah AH; Kazemali MR
    Eur J Pharm Sci; 2022 Jun; 173():106171. PubMed ID: 35378209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Overview of Analytical Techniques for Evaluation of Nano-DDS Formulations].
    Sakai-Kato K
    Yakugaku Zasshi; 2019; 139(2):255-260. PubMed ID: 30713236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical process parameters in manufacturing of liposomal formulations of amphotericin B.
    Rivnay B; Wakim J; Avery K; Petrochenko P; Myung JH; Kozak D; Yoon S; Landrau N; Nivorozhkin A
    Int J Pharm; 2019 Jun; 565():447-457. PubMed ID: 31071418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
    Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
    J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and optimization of TPGS-based stealth liposome of doxorubicin using Box-Behnken design: characterization, hemocompatibility, and cytotoxicity evaluation in breast cancer cells.
    Kurmi BD; Paliwal SR
    J Liposome Res; 2022 Jun; 32(2):129-145. PubMed ID: 33724151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation.
    Parot J; Caputo F; Mehn D; Hackley VA; Calzolai L
    J Control Release; 2020 Apr; 320():495-510. PubMed ID: 32004590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications.
    Panahi Y; Farshbaf M; Mohammadhosseini M; Mirahadi M; Khalilov R; Saghfi S; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):788-799. PubMed ID: 28278586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes: Advancements and innovation in the manufacturing process.
    Shah S; Dhawan V; Holm R; Nagarsenker MS; Perrie Y
    Adv Drug Deliv Rev; 2020; 154-155():102-122. PubMed ID: 32650041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic behaviors of soft nanoparticulate formulations of chemotherapeutics.
    Sarkar M; Wang Y; Ekpenyong O; Liang D; Xie H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Mar; 15(2):e1846. PubMed ID: 35979879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A quality by design approach for the development of lyophilized liposomes with simvastatin.
    Porfire A; Muntean DM; Rus L; Sylvester B; Tomuţă I
    Saudi Pharm J; 2017 Nov; 25(7):981-992. PubMed ID: 29158704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.
    Man F; Gawne PJ; T M de Rosales R
    Adv Drug Deliv Rev; 2019 Mar; 143():134-160. PubMed ID: 31170428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity.
    Gkionis L; Campbell RA; Aojula H; Harris LK; Tirella A
    Int J Pharm; 2020 Nov; 590():119926. PubMed ID: 33010397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.